Journey Medical Corp Research and Development Expense
Journey Medical Corp (DERM) reported Research and Development Expense of $54.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-12
- Journey Medical Corp research and development expense for the quarter ending 2026-06-30 was $54.00K.
- Journey Medical Corp research and development expense for the quarter ending 2025-12-31 was $154.00K, a 29.36% decline year-over-year.
- Journey Medical Corp research and development expense for the quarter ending 2025-09-30 was $287.00K, a 65.91% decline year-over-year.
- Journey Medical Corp research and development expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Journey Medical Corp research and development expense for fiscal 2025 was $480.00K, a 95.13% decline from fiscal 2024.
- Journey Medical Corp research and development expense for fiscal 2024 was $9.86M, a 30.71% increase from fiscal 2023.
- Journey Medical Corp research and development expense for fiscal 2023 was $7.54M, a 31.09% decline from fiscal 2022.
- Journey Medical Corp research and development expense for fiscal 2022 was $10.94M, a 299.53% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $54.00K 10-Q · filed 2026-08-12 | $54.00K 10-Q · filed 2026-08-12 | ||
| 2025-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $441.00K derived: sum of 2 quarters · filed 2026-03-26 | $441.00K derived: sum of 3 quarters · filed 2026-08-12 | $480.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $287.00K 10-Q · filed 2025-11-12 | $287.00K derived: sum of 2 quarters · filed 2026-08-12 | $326.00K 10-Q · filed 2025-11-12 | $544.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $39.00K 10-Q · filed 2026-08-12 | $257.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.10M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $39.00K 10-Q · filed 2026-05-13 | $257.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.10M derived: sum of 3 quarters · filed 2026-05-13 | $2.01M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.06M derived: sum of 2 quarters · filed 2026-03-26 | $1.97M derived: sum of 3 quarters · filed 2026-03-26 | $9.86M 10-K · filed 2026-03-26 |
| 2024-09-30 | $842.00K 10-Q · filed 2025-11-12 | $1.75M derived: sum of 2 quarters · filed 2025-11-12 | $9.64M 10-Q · filed 2025-11-12 | $11.14M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $913.00K 10-Q · filed 2025-08-12 | $8.80M 10-Q · filed 2025-08-12 | $10.30M derived: sum of 3 quarters · filed 2025-08-12 | $12.53M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $7.88M 10-Q · filed 2025-05-15 | $9.39M derived: sum of 2 quarters · filed 2025-05-15 | $11.62M derived: sum of 3 quarters · filed 2025-05-15 | $13.39M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $3.73M derived: sum of 2 quarters · filed 2025-03-27 | $5.51M derived: sum of 3 quarters · filed 2025-03-27 | $7.54M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.23M 10-Q · filed 2024-11-12 | $4.00M derived: sum of 2 quarters · filed 2024-11-12 | $6.04M 10-Q · filed 2024-11-12 | $10.29M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.77M 10-Q · filed 2024-08-13 | $3.81M 10-Q · filed 2024-08-13 | $8.06M derived: sum of 3 quarters · filed 2024-08-13 | $10.88M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.03M 10-Q · filed 2024-05-14 | $6.29M derived: sum of 2 quarters · filed 2024-05-14 | $9.10M derived: sum of 3 quarters · filed 2024-05-14 | $11.71M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $7.07M derived: sum of 2 quarters · filed 2024-03-29 | $9.68M derived: sum of 3 quarters · filed 2024-03-29 | $10.94M 10-K · filed 2024-03-29 |
| 2022-09-30 | $2.81M 10-Q · filed 2023-11-13 | $5.42M derived: sum of 2 quarters · filed 2023-11-13 | $6.69M 10-Q · filed 2023-11-13 | $8.68M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $2.61M 10-Q · filed 2023-08-10 | $3.88M 10-Q · filed 2023-08-10 | $5.87M derived: sum of 3 quarters · filed 2023-08-10 | $6.58M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.27M 10-Q · filed 2023-05-22 | $3.26M derived: sum of 2 quarters · filed 2023-05-22 | $3.98M derived: sum of 3 quarters · filed 2023-05-22 | $4.00M derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.71M derived: sum of 2 quarters · filed 2023-03-31 | $2.74M derived: sum of 3 quarters · filed 2023-03-31 | $2.74M 10-K · filed 2023-03-31 |
| 2021-09-30 | $718.00K 10-Q · filed 2022-11-10 | $747.00K derived: sum of 2 quarters · filed 2022-11-10 | $747.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $29.00K 10-Q · filed 2022-08-09 | $29.00K 10-Q · filed 2022-08-09 |